Page last updated: 2024-11-05

2,5-norbornadiene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID8473
MeSH IDM0139036

Synonyms (47)

Synonym
bicyclo(2.2.1)hepta-2,5-diene
nsc 13672
8,9,10-trinorborna-2,5-diene
bicyclo(2.2.1)heptadiene
einecs 204-472-0
un2251
ai3-24887
2,5-norbornadiene ,
nsc13672
nsc-13672
121-46-0
bicyclo[2.2.1]hepta-2,5-diene
norbornadiene
inchi=1/c7h8/c1-2-7-4-3-6(1)5-7/h1-4,6-7h,5h
NBD ,
nsc167540
16422-76-7
bicyclo[2.2.1]hepta-2, dimer, stereoisomer
nsc-167540
bicyclo[2.2.1]hepta-2,5-diene, 98%
AKOS005145646
N0346
EN300-93414
AKOS016008675
w9ztq75zus ,
bicyclo(2,2,1)hepta-2,5-diene, inhibited or 2,5-norborandiene, inhibited [un2251] [flammable liquid]
bicyclo(2,2,1)hepta-2,5-diene, inhibited or 2,5-norborandiene, inhibited
unii-w9ztq75zus
FT-0610499
AKOS015912918
2,5-norbornadiene (stabilized with bht)
bicyclo-(2,2,1)-hepta-2,5-diene
3,6-methano-1,4-cyclohexadiene
norbornadiene [mi]
un-2251
DTXSID1059523
bicyclo[2.2.1]heptadiene
dicycloheptadiene
bicyclo[2.2.1]-2,5-heptadiene
STL453640
J-004501
mfcd00082301
(1s,4s)-bicyclo[2.2.1]hepta-2,5-diene
2,5-dicycloheptadiene
2,5-norbornadiene, (stabilized with bht)
Q726795
bicyclo[2.2.1]hepta-2,5-diene,(norbornadiene)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (8.70)18.7374
1990's4 (17.39)18.2507
2000's11 (47.83)29.6817
2010's6 (26.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.24 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]